drugset / Trial / NCT02029066

Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis

NCT02029066 ↗

Phase 1 Completed 2 enrolled G&E Herbal Biotechnology Co., LTD
NaSingle-groupOpen-label

Summary

This study is designed to evaluate the pharmacokinetics of solamargine of SR-T100 gel. As safety parameters, adverse events, and vital signs (blood pressure, heart rate, and body temperature) will be recorded.

Timeline

Start
2013-11
Primary completion
2014-02
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Subject solamargine Small molecule 2 g Topical

Indications